Literature DB >> 19887380

TWEAK is a positive regulator of cardiomyocyte proliferation.

Tatyana Novoyatleva1, Florian Diehl, Machteld J van Amerongen, Chinmoy Patra, Fulvia Ferrazzi, Riccardo Bellazzi, Felix B Engel.   

Abstract

AIMS: Proliferation of mammalian cardiomyocytes stops during the first weeks after birth, preventing the heart from regenerating after injury. Recently, several studies have indicated that induction of cardiomyocyte proliferation can be utilized to regenerate the mammalian heart. Thus, it is important to identify novel factors that can induce proliferation of cardiomyocytes. Here, we determine the effect of TNF-related weak inducer of apoptosis (TWEAK) on cardiomyocytes, a cytokine known to regulate proliferation in several other cell types. METHODS AND
RESULTS: Stimulation of neonatal rat cardiomyocytes with TWEAK resulted in increased DNA synthesis, increased expression of the proliferative markers Cyclin D2 and Ki67, and downregulation of the cell cycle inhibitor p27KIP1. Importantly, TWEAK stimulation resulted also in mitosis (H3P), cytokinesis (Aurora B), and increased cardiomyocyte numbers. Loss of function experiments revealed that re-induction of proliferation was dependent on tumour necrosis factor receptor superfamily member 12A (FN14) signalling. Downstream signalling was mediated through activation of extracellular signal-regulated kinases and phosphatidylinositol 3-kinase as well as inhibition of glycogen synthase kinase-3beta. In contrast to neonatal cardiomyocytes, TWEAK had no effect on adult rat cardiomyocytes due to developmental downregulation of its receptor FN14. However, adenoviral expression of FN14 enabled efficient induction of cell cycle re-entry in adult cardiomyocytes after TWEAK stimulation.
CONCLUSION: Our data establish TWEAK as a positive regulator of cardiomyocyte proliferation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19887380     DOI: 10.1093/cvr/cvp360

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  42 in total

Review 1.  Control of autocrine and paracrine myocardial signals: an emerging therapeutic strategy in heart failure.

Authors:  Vincenzo Lionetti; Giacomo Bianchi; Fabio A Recchia; Carlo Ventura
Journal:  Heart Fail Rev       Date:  2010-11       Impact factor: 4.214

Review 2.  Role of TWEAK in lupus nephritis: a bench-to-bedside review.

Authors:  Jennifer S Michaelson; Nicolas Wisniacki; Linda C Burkly; Chaim Putterman
Journal:  J Autoimmun       Date:  2012-06-22       Impact factor: 7.094

Review 3.  Therapeutic potential of menstrual blood-derived endometrial stem cells in cardiac diseases.

Authors:  Yanli Liu; Rongcheng Niu; Wenzhong Li; Juntang Lin; Christof Stamm; Gustav Steinhoff; Nan Ma
Journal:  Cell Mol Life Sci       Date:  2019-02-05       Impact factor: 9.261

Review 4.  Understanding cardiomyocyte proliferation: an insight into cell cycle activity.

Authors:  Murugavel Ponnusamy; Pei-Feng Li; Kun Wang
Journal:  Cell Mol Life Sci       Date:  2016-09-30       Impact factor: 9.261

5.  Mining disease fingerprints from within genetic pathways.

Authors:  Ahmed Ragab Nabhan; Indra Neil Sarkar
Journal:  AMIA Annu Symp Proc       Date:  2012-11-03

6.  Acute myocardial infarction induced functional cardiomyocytes to re-enter the cell cycle.

Authors:  Yongjun Li; Shengda Hu; Genshan Ma; Yuyu Yao; Gaoliang Yan; Jia Chen; Yefei Li; Zhuoli Zhang
Journal:  Am J Transl Res       Date:  2013-04-19       Impact factor: 4.060

Review 7.  The TWEAK-Fn14 pathway: a potent regulator of skeletal muscle biology in health and disease.

Authors:  Marjan M Tajrishi; Timothy S Zheng; Linda C Burkly; Ashok Kumar
Journal:  Cytokine Growth Factor Rev       Date:  2013-12-24       Impact factor: 7.638

8.  Hypoxia inhibits cardiomyocyte proliferation in fetal rat hearts via upregulating TIMP-4.

Authors:  Wenni Tong; Fuxia Xiong; Yong Li; Lubo Zhang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-20       Impact factor: 3.619

Review 9.  Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease.

Authors:  Keith Richard Mitchelson; Wen-Yan Qin
Journal:  World J Biol Chem       Date:  2015-08-26

10.  Cardiomyocyte proliferation: paving the way for cardiac regenerative medicine without stem cell transplantation.

Authors:  Carlo Ventura
Journal:  Cardiovasc Res       Date:  2010-01-05       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.